A Study of the Safety and Efficacy of MK-0773 in Women With Sarcopenia (Loss of Muscle Mass)(MK-0773-005)

A Phase IIa Randomized, Placebo-Controlled Clinical Trial to Study the Efficacy and Safety of MK-0773 in Patients With Sarcopenia

A study to evaluate the safety, tolerability, and efficacy of MK-0773 in women with sarcopenia (loss of muscle mass).

Inclusion Criteria:

• Patient is a woman who is 65 years of age or older
• Patient's lean body mass is at least 1 standard deviation below the mean of a healthy young adult population
• Patient has difficulty climbing 10 steps or walking outside on level ground for 1/4 mile without resting or Activity Measure for Post Acute Care (AM-PAC)<66

Exclusion Criteria:

• Patient has serious neurological, rheumatologic, cardiac, respiratory, kidney, psychiatric conditions
• Patient has a history of certain types of cancer